JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2015, 64(6):284-286

Antioxidative protection of inactivated rabies vaccine with squalene adjuvant by β-carotene

Judit Süli1,*, Linda Kolčáková1, Jarmila Harvanová1, Anna Ondrejková2
1 Department of Chemistry, Biochemistry and Biophysics, University of Veterinary Medicine and Pharmacy, Košice, Slovak Republic
2 Department of Epizootiology and Parasitology, University of Veterinary Medicine and Pharmacy, Košice, Slovak Republic

Published: June 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Süli J, Kolčáková L, Harvanová J, Ondrejková A. Antioxidative protection of inactivated rabies vaccine with squalene adjuvant by β-carotene. Čes. slov. farm. 2015;64(6):284-286.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mori A., Oleszycka E., Sharp F. A., Coleman M., Ozasa Y., Singh M., O'Hagan D. T., Tajber L. The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses. Eur. J. Immunol. 2012; 42, 2709-2719. Go to original source... Go to PubMed...
    2. Tomljenovic L., Shaw C. A. Aluminium vaccine adjuvants: are they safe? Curr. Med. Chem. 2011; 18, 2630-2637. Go to original source... Go to PubMed...
    3. Fox C.B. Squalene emulsions for parenteral vaccine and drug delivery. Molecules 2009; 14, 3286-3312. Go to original source... Go to PubMed...
    4. Süli J., Lovásová M., Sobeková A. Antioxidative protection of squalene vaccination adjuvants. Folia Vet. 2012; 56(Suppl II), 56-58.
    5. Süli J., Beníšek Z., Eliáš D., Švrček Š., Ondrejková A., Ondrejka R., Bajová V. Experimental squalene adjuvant. I. Preparation and testing of its effectiveness. Vaccine 2004; 22, 3464-3469. Go to original source... Go to PubMed...
    6. Ondrejková A., Süli J., Kolčáková L., Ondrejka R., Čechvala P., Benkö Z., Prokeš M. Influence of β-carotene on antigenic effectiveness of inactivated rabies vaccine with squalene adjuvant. In: Sborník 44. Konference Syntéza a analýza liečiv. Brno: 2015.
    7. Slepecká E., Süli J., Radová J., Ondrejková A., Ondrejka R., Prokeš M., Korytár Ľ., Čechvala P., Harvanová J. Stanovenie fyzikálno-chemických vlastností a sledovanie stability skvalénových emulzií. Chem. Listy 2013; 107, 659-664.
    8. Nakagawa K., Ibusuki D., Suzuki Y., Yamashita S., Higuchi O., Oikawa S., Miyazawa T. Ion-trap tandem mass spectrometric analysis of squalene monohydroperoxide isomers in sunlight-exposed human skin. J. Lipid Res. 2007; 48, 2779-2787. Go to original source... Go to PubMed...
    9. Popa I., Băăbeanu N. E., Niţă S., Popa O., Dinu-Pârvu C. E. Squalene - natural resources and applications. Farmacia 2014; 62, 840-862.
    10. Huang Z. R., Lin Y. K., Fang J. Y. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules 2009; 14, 540-554. Go to original source... Go to PubMed...

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.